Literature DB >> 20661604

Interleukin-10 gene polymorphisms in association with susceptibility to chronic hepatitis C virus infection: a meta-analysis study.

Li-Zhou Zhang1, Tian-Chen Zhang, Fa-Ming Pan, Zhen-Hua Zhang, Xu Li.   

Abstract

A relationship between chronic hepatitis C virus (HCV) infection and interleukin-10 (IL-10) gene polymorphisms has been reported with controversial results in different studies. In an effort to solve this controversy, we quantitatively summarized ten studies on this relationship by means of meta-analysis. Our analysis included ten case-control studies with 992 cases of chronic HCV infection and 1,123 controls. Analyses were performed with STATA version 9.0. The results showed that the IL-10 -1082GG genotype significantly increased the risk for persistent HCV infection (AA vs. GG: OR = 0.680, 95% CI = 0.489-0.947, P = 0.022; AG vs. GG: OR = 0.608, 95% CI = 0.439-0.840, P = 0.003; GG vs. AG + AA: OR = 1.570, 95% CI = 1.160-2.123, P = 0.003), but no statistically significant differences were observed between cases and controls for IL-10 -819C/T and IL-10 -592C/A polymorphisms (P > 0.05). In conclusion, this meta-analysis suggested that the IL-10 -1082GG genotype was associated with increased susceptibility for chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661604     DOI: 10.1007/s00705-010-0757-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  Association of interleukin-10 gene promoter polymorphisms with susceptibility to acute pyelonephritis in children.

Authors:  Juraj Javor; Karol Králinský; Eva Sádová; Oľga Červeňová; Mária Bucová; Michaela Olejárová; Milan Buc; Adriana Liptáková
Journal:  Folia Microbiol (Praha)       Date:  2014-01-22       Impact factor: 2.099

2.  Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children.

Authors:  Guicheng Zhang; Maria Nelia Manaca; Michelle McNamara-Smith; Alfredo Mayor; Augusto Nhabomba; Tamara Katherine Berthoud; Siew-Kim Khoo; Selma Wiertsema; Ruth Aguilar; Arnoldo Barbosa; Llorenç Quintó; Pierre Candelaria; En Nee Schultz; Catherine M Hayden; Jack Goldblatt; Caterina Guinovart; Pedro L Alonso; Peter N Lesouëf; Carlota Dobaño
Journal:  Infect Immun       Date:  2012-05-07       Impact factor: 3.441

3.  IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort.

Authors:  Alajos Pár; Gabriella Pár; István Tornai; Ferenc Szalay; Dalma Várszegi; Edit Fráter; Mária Papp; Gabriella Lengyel; János Fehér; Márta Varga; Judit Gervain; János Schuller; Zsuzsanna Nemes; Zoltán Péterfi; Anna Tusnádi; Béla Hunyady; Attila Haragh; Zsolt Szinku; Aron Vincze; László Szereday; Péter Kisfali; Béla Melegh
Journal:  BMC Res Notes       Date:  2014-01-08

4.  Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy.

Authors:  A J Khan; V A Saraswat; G Choudhuri; D Parmar; T S Negi; S Mohindra
Journal:  Epidemiol Infect       Date:  2014-03-18       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.